Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:58 AM
Ignite Modification Date:
2025-12-25 @ 4:58 AM
NCT ID:
NCT01670318
Eligibility Criteria:
Inclusion Criteria:
1. A patient with ischemic heart disease including stable angina pectoris and acute coronary syndrome
2. Male or non-pregnant female
3. Key lesion inclusion criteria as follows
1. Multi-vessel diseases
2. Long lesion (lesion length \>30mm by visual estimation)
3. Small vessel disease (reference diameter \<2.5mm by visual estimation)
4. Bifurcation lesion
5. Ostial lesion
6. Calcified lesion
7. Protected or non-protected left main trunk disease
8. Chronic total occlusion
9. In stent restenosis of bare metal stent or everolimus-eluting stent
Exclusion Criteria:
1. Hypersensitivity to cobalt chromium, everolimus, heparin, aspirin, ticlopidine, clopidogrel or X-ray contrast media.
2. Serum creatinine level \>3.0 mg/dL
3. Other concomitant disease or medical condition that could impact patient/procedural outcomes, such as history of bleeding diathesis or cancer within 5 years.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
85 Years
Study:
NCT01670318
Study Brief:
Protocol Section:
NCT01670318